Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus

Transplantation

Volumn 88, Issue 2, 2009, Pages 261-265

  Kihm, Lars P ^a   Hinkel, Ulrich Paul ^a   Michael, Kayla ^a   Sommerer, Claudia ^a   Seckinger, Joerg ^a   Morath, Christian ^a   Zeier, Martin ^a   Schwenger, Vedat ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Microperfusion; mTOR inhibitor; Renal allograft; Ultrasound

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; MYCOPHENOLIC ACID; SONOVUE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT PERFUSION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY PERFUSION; KIDNEY POLYCYSTIC DISEASE; LEUKOCYTOSIS; LEUKOPENIA; MALE; MICROVASCULARIZATION; MYALGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STOMATITIS; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; CREATININE; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; HUMANS; IMAGE ENHANCEMENT; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MICROCIRCULATION; MIDDLE AGED; RENAL CIRCULATION; SIROLIMUS; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 68249093627     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ac8cdd     Document Type: Article

References (29)

1. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
2. Kreis HA, Ponticelli C. Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 2001; 71: SS5.
3. Krumme B, Grotz W, Kirste G, et al. Determinants of intrarenal Doppler indices in stable renal allografts. J Am Soc Nephrol 1997; 8: 813.
4. Schwenger V, Korosoglou G, Hinkel UP, et al. Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant 2006; 6: 609.
5. Schwenger V, Hinkel UP, Nahm AM, et al. Color doppler ultrasonography in the diagnostic evaluation of renal allografts. Nephron Clin Pract 2006; 104: c107.
6. Schwenger V, Keller T, Hofmann N, et al. Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients. Am J Transplant 2006; 6: 2721.
7. Sommerer C, Hergesell O, Nahm AM, et al. Cyclosporin A toxicity of the renal allograft - A late complication and potentially reversible. Nephron 2002; 92: 339.
8. Young LS, Regan MC, Barry MK, et al. Methods of renal blood flow measurement. Urol Res 1996; 24: 149.
9. Dubovsky EV, Russell CD, Bischof-Delaloye A, et al. Report of the Radionuclides in Nephrourology Committee for evaluation of transplanted kidney (review of techniques). Semin Nucl Med 1999; 29: 175.
10. Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004; 25: 249.
11. Nankivell BJ, Gruenewald SM, Allen RD, et al. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995; 59: 1683.
12. Morales J, Fierro A, Benavente D, et al. Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: Effect on renal function and proteinuria. Transplant Proc 2007; 39: 591.
13. Mota A, Arias M, Taskinen EI, et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953.
14. Oberbauer R, Segoloni G, Campistol JM, et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int 2005; 18: 22.
15. Chapman JR, Valantine H, Albanell J, et al. Proliferation signal inhibitors in transplantation: Questions at the cutting edge of everolimus therapy. Transplant Proc 2007; 39: 2937.
16. O'Reilly KE, Rojo F, She QB, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006; 66: 1500.
17. Ponticelli C. The pleiotropic effects of mTor inhibitors. J Nephrol 2004; 17: 762.
18. First MR, Neylan JF, Rocher LL, et al. Hypertension after renal transplantation. J Am Soc Nephrol 1994; 4: S30.
19. Schwenger V, Zeier M, Ritz E. Hypertension after renal transplantation. Ann Transplant 2001; 6: 25.
20. Iwai J, Kanayama Y, Negoro N, et al. Gene expression of endothelin receptors in aortic cells from cyclosporine-induced hypertensive rats. Clin Exp Pharmacol Physiol 1995; 22: 404.
21. Nankivell BJ, Chapman JR, Bonovas G, et al. Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation 2004; 77: 1457.
22. Perico N, Ruggenenti P, Gaspari F, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54: 56.
23. Watarai Y, Morita K, Shimoda N, et al. Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production. Transplant Proc 2004; 36: 2130.
24. Ay T, Havaux X, Van Camp G, et al. Destruction of contrast microbubbles by ultrasound: Effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation 2001; 104: 461.
25. Fischer T, Filimonow S, Dieckhofer J, et al. Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer - A new method for the diagnosis of renal perfusion. Nephrol Dial Transplant 2006; 21: 2921.
26. Wei K, Le E, Bin JP, et al. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 2001; 37: 1135.
27. Price RJ, Skyba DM, Kaul S, et al. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998; 98: 1264.
28. Lindner JR. Evolving applications for contrast ultrasound. Am J Cardiol 2002; 90: 72J.
29. Bekeredjian R, Chen S, Frenkel PA, et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022.